• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HELLPAR/RRM2 轴与 HMMR 作为胶质瘤的新型预后生物标志物相关。

HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas.

机构信息

Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Nanchang, 330006, Jiangxi, China.

Huankui Academy, Nanchang University, Honggutan New District, Jiangxi, 330006, Nanchang, China.

出版信息

BMC Cancer. 2023 Feb 7;23(1):125. doi: 10.1186/s12885-023-10596-w.

DOI:10.1186/s12885-023-10596-w
PMID:36750807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9903609/
Abstract

BACKGROUND

Gliomas are the most frequent type of central nervous system tumor, accounting for more than 70% of all malignant CNS tumors. Recent research suggests that the hyaluronan-mediated motility receptor (HMMR) could be a novel potential tumor prognostic marker. Furthermore, mounting data has highlighted the important role of ceRNA regulatory networks in a variety of human malignancies. The complexity and behavioural characteristics of HMMR and the ceRNA network in gliomas, on the other hand, remained unknown.

METHODS

Transcriptomic expression data were collected from TCGA, GTEx, GEO, and CGGA database.The relationship between clinical variables and HMMR was analyzed with the univariate and multivariate Cox regression. Kaplan-Meier method was used to assess OS. TCGA data are analyzed and processed, and the correlation results obtained were used to perform GO, GSEA, and ssGSEA. Potentially interacting miRNAs and lncRNAs were predicted by miRWalk and StarBase.

RESULTS

HMMR was substantially expressed in gliomas tissues compared to normal tissues. Multivariate analysis revealed that high HMMR expression was an independent predictive predictor of OS in TCGA and CGGA. Functional enrichment analysis found that HMMR expression was associated with nuclear division and cell cycle. Base on ssGSEA analysis, The levels of HMMR expression in various types of immune cells differed significantly. Bioinformatics investigation revealed the HEELPAR-hsa-let-7i-5p-RRM2 ceRNA network, which was linked to gliomas prognosis. And through multiple analysis, the good predictive performance of HELLPAR/RRM2 axis for gliomas patients was confirmed.

CONCLUSION

This study provides multi-layered and multifaceted evidence for the importance of HMMR and establishes a HMMR-related ceRNA (HEELPAR-hsa-let-7i-5p-RRM2) overexpressed network related to the prognosis of gliomas.

摘要

背景

神经胶质瘤是最常见的中枢神经系统肿瘤,占所有恶性中枢神经系统肿瘤的 70%以上。最近的研究表明,透明质酸介导的运动受体(HMMR)可能是一种新的潜在肿瘤预后标志物。此外,越来越多的数据强调了 ceRNA 调控网络在多种人类恶性肿瘤中的重要作用。另一方面,HMMR 和神经胶质瘤中 ceRNA 网络的复杂性和行为特征尚不清楚。

方法

从 TCGA、GTEx、GEO 和 CGGA 数据库中收集转录组表达数据。使用单变量和多变量 Cox 回归分析 HMMR 与临床变量之间的关系。Kaplan-Meier 方法用于评估 OS。分析 TCGA 数据并进行处理,将获得的相关结果用于进行 GO、GSEA 和 ssGSEA 分析。通过 miRWalk 和 StarBase 预测潜在相互作用的 miRNAs 和 lncRNAs。

结果

HMMR 在神经胶质瘤组织中的表达明显高于正常组织。多变量分析显示,高 HMMR 表达是 TCGA 和 CGGA 中 OS 的独立预测指标。功能富集分析发现 HMMR 表达与核分裂和细胞周期有关。基于 ssGSEA 分析,各种免疫细胞中 HMMR 表达水平差异显著。生物信息学研究揭示了与神经胶质瘤预后相关的 HEELPAR-hsa-let-7i-5p-RRM2 ceRNA 网络。通过多种分析,证实了 HELLPAR/RRM2 轴对神经胶质瘤患者具有良好的预测性能。

结论

本研究为 HMMR 的重要性提供了多层次、多方面的证据,并建立了与神经胶质瘤预后相关的 HMMR 相关 ceRNA(HEELPAR-hsa-let-7i-5p-RRM2)过表达网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d575e2116d40/12885_2023_10596_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e0b2879e6285/12885_2023_10596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e889c5f7ced0/12885_2023_10596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/262030efc1c5/12885_2023_10596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d0e50fde06ec/12885_2023_10596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/bd4ef855e8d6/12885_2023_10596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/17834098ce2b/12885_2023_10596_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e6d6708a14a1/12885_2023_10596_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/5c4297d03bca/12885_2023_10596_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/3f64596412bf/12885_2023_10596_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/b5fdd9473381/12885_2023_10596_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/58e2d95290ac/12885_2023_10596_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d8f3fc616458/12885_2023_10596_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d575e2116d40/12885_2023_10596_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e0b2879e6285/12885_2023_10596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e889c5f7ced0/12885_2023_10596_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/262030efc1c5/12885_2023_10596_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d0e50fde06ec/12885_2023_10596_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/bd4ef855e8d6/12885_2023_10596_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/17834098ce2b/12885_2023_10596_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/e6d6708a14a1/12885_2023_10596_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/5c4297d03bca/12885_2023_10596_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/3f64596412bf/12885_2023_10596_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/b5fdd9473381/12885_2023_10596_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/58e2d95290ac/12885_2023_10596_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d8f3fc616458/12885_2023_10596_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0823/9903609/d575e2116d40/12885_2023_10596_Fig13_HTML.jpg

相似文献

1
HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas.HELLPAR/RRM2 轴与 HMMR 作为胶质瘤的新型预后生物标志物相关。
BMC Cancer. 2023 Feb 7;23(1):125. doi: 10.1186/s12885-023-10596-w.
2
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.MCM10 作为一种新型的预后生物标志物及其与胶质瘤免疫浸润的相关性。
Technol Health Care. 2023;31(4):1301-1317. doi: 10.3233/THC-220576.
3
High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.透明质酸介导的运动受体高表达预示不良预后:头颈部鳞状细胞癌的潜在治疗靶点
Front Oncol. 2021 Mar 8;11:608842. doi: 10.3389/fonc.2021.608842. eCollection 2021.
4
Construction of a ceRNA network in glioma and analysis of its clinical significance.构建胶质瘤 ceRNA 网络并分析其临床意义。
BMC Genomics. 2021 Oct 6;22(1):722. doi: 10.1186/s12864-021-08035-w.
5
Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.ASF1B表达增加与胶质瘤患者的不良预后相关。
Front Oncol. 2022 Jul 6;12:912101. doi: 10.3389/fonc.2022.912101. eCollection 2022.
6
Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.鉴定lncRNA/circRNA-miRNA-mRNA ceRNA网络作为肝细胞癌的生物标志物
Front Genet. 2022 Mar 21;13:838869. doi: 10.3389/fgene.2022.838869. eCollection 2022.
7
Validating Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods.基于数据挖掘和生物信息学方法验证肺腺癌中的表达及其预后意义
Front Oncol. 2021 Aug 30;11:720302. doi: 10.3389/fonc.2021.720302. eCollection 2021.
8
HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.HMMR 与免疫浸润物相关,并作为肺腺癌的预后生物标志物。
Comput Biol Med. 2022 Dec;151(Pt A):106213. doi: 10.1016/j.compbiomed.2022.106213. Epub 2022 Oct 23.
9
NcRNA-Mediated High Expression of as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma.ncRNA介导的[具体基因名称未给出]高表达作为与肺腺癌细胞增殖和细胞迁移相关的预后生物标志物
Front Oncol. 2022 Mar 3;12:846536. doi: 10.3389/fonc.2022.846536. eCollection 2022.
10
Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.基于综合生物信息学分析鉴定HMMR基因作为肝细胞癌的诊断和预后生物标志物
Evid Based Complement Alternat Med. 2021 Jun 15;2021:5970085. doi: 10.1155/2021/5970085. eCollection 2021.

引用本文的文献

1
Targeting RHAMM in Cancer: Crosstalk with Non-Coding RNAs and Emerging Therapeutic Strategies Including Peptides, Oligomers, Antibodies, and Vaccines.癌症中靶向透明质酸介导的运动受体(RHAMM):与非编码RNA的相互作用及新兴治疗策略,包括肽、寡聚物、抗体和疫苗
Int J Mol Sci. 2025 Jul 25;26(15):7198. doi: 10.3390/ijms26157198.
2
Interfered long non-coding RNA HELLPAR or up-regulated microRNA-448 inhibits nasopharyngeal carcinoma progression via suppression of ADAM10.干扰性长链非编码RNA HELLPAR或上调的微小RNA-448通过抑制ADAM10来抑制鼻咽癌进展。
Discov Oncol. 2025 May 21;16(1):849. doi: 10.1007/s12672-025-02565-5.
3
FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy.

本文引用的文献

1
The Emerging Roles of LINC00665 in Human Cancers.LINC00665在人类癌症中的新兴作用
Front Cell Dev Biol. 2022 Mar 9;10:839177. doi: 10.3389/fcell.2022.839177. eCollection 2022.
2
Proteomics and metabolomics approach in adult and pediatric glioma diagnostics.蛋白质组学和代谢组学方法在成人和儿童脑胶质瘤诊断中的应用。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188721. doi: 10.1016/j.bbcan.2022.188721. Epub 2022 Mar 16.
3
Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.
FOXM1 通过促进自噬介导骨肉瘤细胞对甲氨蝶呤的耐药性。
Acta Biochim Biophys Sin (Shanghai). 2024 Jul 31;56(9):1289-1299. doi: 10.3724/abbs.2024084.
卡博替尼增强抗PD-1活性并在肝细胞癌中引发基于中性粒细胞的免疫反应。
Clin Cancer Res. 2022 Jun 1;28(11):2449-2460. doi: 10.1158/1078-0432.CCR-21-2517.
4
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy.TGFβ 受体抑制作用释放肿瘤相关巨噬细胞中的干扰素-β产生并增强放射治疗效果。
J Immunother Cancer. 2022 Mar;10(3). doi: 10.1136/jitc-2021-003519.
5
Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.成人型弥漫性胶质瘤分类:世界卫生组织 2021 年更新的影响。
Brain Pathol. 2022 Jul;32(4):e13062. doi: 10.1111/bpa.13062. Epub 2022 Mar 14.
6
Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.基质重塑相关蛋白 8 通过调控铁死亡作为一种新的胶质瘤免疫反应的标志物。
Front Immunol. 2022 Feb 24;13:834595. doi: 10.3389/fimmu.2022.834595. eCollection 2022.
7
Systematic Analysis of the Clinical Significance of Hyaluronan-Mediated Motility Receptor in Colorectal Cancer.透明质酸介导的运动受体在结直肠癌中临床意义的系统分析
Front Mol Biosci. 2021 Oct 26;8:733271. doi: 10.3389/fmolb.2021.733271. eCollection 2021.
8
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas.溶瘤病毒免疫治疗:脑胶质瘤治疗的新选择
Front Immunol. 2021 Oct 5;12:721830. doi: 10.3389/fimmu.2021.721830. eCollection 2021.
9
Identification of autophagic target RAB13 with small-molecule inhibitor in low-grade glioma via integrated multi-omics approaches coupled with virtual screening of traditional Chinese medicine databases.通过整合多组学方法并结合中药数据库的虚拟筛选,鉴定低级别神经胶质瘤自噬靶点 RAB13 的小分子抑制剂。
Cell Prolif. 2021 Dec;54(12):e13135. doi: 10.1111/cpr.13135. Epub 2021 Oct 10.
10
HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells.HMMR 是 FOXM1 增强膀胱癌细胞增殖和部分上皮间质转化的下游靶标。
Exp Cell Res. 2021 Nov 15;408(2):112860. doi: 10.1016/j.yexcr.2021.112860. Epub 2021 Oct 5.